Humanoid robotics: what’s funding like now?

Last updated: 22 September 2026

All funding deals in the humanoid robotics market over the last 24 months

Below is the table listing all the deals. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the Humanoid Robotics Market.

Is humanoid robotics funding actually healthier right now?

Humanoid robotics funding looks clearly healthier today: more companies are raising money, more deals are closing, and the typical round has become much larger.

We counted 77 financings in the latest 12-month period, compared with 63 in the previous one. The number of funded companies rose almost as quickly, from 44 to 54, so the extra activity is reaching a wider group of businesses.

The jump in capital is much bigger. We calculate about $6.48 billion of disclosed or conservatively quantified funding, up from $2.56 billion. More importantly, the median financing increased from $14 million to $32.3 million. The improvement runs much deeper than one huge deal at the top.

There is still a data-quality caveat. A large share of Chinese rounds are disclosed as approximate amounts or lower bounds, so the dollar totals should be treated as minimum or near-minimum figures. Amount coverage has actually improved, however: 90.9% of current deals have a usable figure, versus 76.2% in the previous period.

Metric	Latest 12M	Previous 12M	Change
Deals	77	63	+22.2%
Funded companies	54	44	+22.7%
Disclosed/minimum capital	$6.48B	$2.563B	+152.8%
Median round	$32.3M	$14.0M	+131.5%
Average round	$92.6M	$53.4M	+73.4%
First financings	13	9	+44.4%
Capital excluding >$50M rounds	$865.8M	$572.8M	+51.2%
Capital excluding >$100M rounds	$1.186B	$920.2M	+28.9%

Is the humanoid robotics funding boom still real without the megadeals?

It is. Humanoid robotics funding still grew comfortably once we removed the giant rounds, which makes the current boom much more convincing.

Excluding every financing above $100 million leaves current funding 28.9% higher than a year earlier. Using an even tougher $50 million cutoff produces a 51.2% increase.

The comparison is especially revealing because the earlier period contained Figure's more-than-$1 billion Series C right before the cutoff. That one financing represented roughly 39% of all quantified capital in the period.

The largest current deal, Apptronik's $520 million extension, accounts for only about 8% of current capital. The three largest rounds together now represent 20.6%, down from 58.6%.

So today's growth is spread across many more large financings. The headline total is high, but the market underneath it is stronger too.

Are more humanoid robotics companies getting funded now?

Yes. Humanoid robotics funding is reaching more companies these days, and repeat rounds from the same handful of startups are not driving the increase.

We found 54 funded businesses in the latest period, 10 more than one year earlier. That company growth closely tracks the rise in deal activity.

Meanwhile, the number of businesses completing multiple financings barely changed, from 16 to 17. Because the overall pool became larger, the repeat-fundraising rate actually slipped from 36.4% to 31.5%.

Monthly activity also became a little steadier. There was at least one financing in every one-month interval in the current period, while the previous period had one empty interval. The median month moved from five deals to six.

The picture is pretty simple: the funding market has widened without becoming dependent on constant fundraising by the same names.

Are investors still backing new humanoid robotics startups?

Yes, although existing humanoid robotics companies are capturing almost all of the extra money once they return for another round.

First financings increased from nine to 13, and the typical first check stayed almost unchanged at around $14 million. New companies are still finding their way into the funded market.

Follow-ons have changed far more. Their median size climbed from $14 million to $47.35 million, while the amount invested through follow-on financings reached roughly $6.22 billion.

This is where the current market looks very different from a year ago. Getting into the funding ecosystem has not suddenly become much more lucrative. The huge step-up comes later, when a startup has enough progress behind it to return for more capital.

Metric	Latest 12M	Previous 12M
First financings	13	9
First-financing share	16.9%	14.3%
Capital in first financings	$256.5M	$87.1M
Median first financing	$14.0M	$13.65M
Follow-on financings	64	53
Capital in follow-ons	$6.22B	$2.48B
Median follow-on financing	$47.35M	$14.0M

Why are humanoid robotics rounds so much bigger now?

Humanoid robotics rounds have moved up an entire size bracket, with $100 million financings becoming surprisingly common.

At the bottom of the market, we counted only four current rounds below $5 million, compared with 12 previously. The $20 million to $50 million range moved the other way, increasing from 11 deals to 19.

Then there is the top end. Twenty-six current financings reached at least $100 million, compared with only four in the previous period.

That helps explain why the average round has risen so strongly even without a single billion-dollar financing. It also fits what we see in the companies themselves: more of the better-funded humanoid businesses are now paying for manufacturing, robot fleets, data collection, compute and real customer deployments.

The financing market has started pricing some young humanoid companies more like scale-ups than experimental robotics startups.

Has humanoid robotics really moved beyond Seed and Series A?

Yes. Humanoid robotics funding currently has a much more visible Series B layer, although incomplete stage disclosure means we should avoid pretending the split is perfectly clean.

Seed represented 38.1% of deals in the previous period and now represents 27.3%. Series A dropped even more sharply, from 41.3% to 20.8%.

Series B went from one financing to 11.

That jump is hard to dismiss, especially because current stage coverage is actually worse. About 35% of recent deals have no reliable public stage, versus around 16% before. If we look only at financings where a stage is known, later-stage rounds increased from roughly 6% to 26% of the total.

Two Growth Equity financings also appeared during the current period.

The humanoid funding market still creates plenty of young companies, but there is now a much larger cohort moving into the next financing phase.

Are humanoid robotics companies raising again faster?

Not much. Humanoid robotics companies were already returning to investors very quickly, and that timing has barely changed.

Among follow-ons where we could identify a previous financing, the median interval moved from 4.62 months to 4.24 months. The average actually increased slightly, from 5.50 to 5.89 months.

The size of the next round changed much more.

For the 35 current financings where both round amounts could be compared, the median new round was twice as large as the previous one. A year earlier, the median step-up was 1.31 times.

Almost half of those current repeat rounds were more than twice the size of the preceding financing.

Companies are coming back at roughly the same rapid pace, but investors are giving successful ones considerably more money when they do.

Do humanoid robotics startups need more proof to raise now?

Humanoid robotics investors seem to be rewarding proof of scalability more aggressively now, although we cannot measure a clean before-and-after "milestone bar" from the public data.

Our dataset does not contain a standardized field for customer revenue, production contracts, deployment milestones or technical validation. Turning company descriptions into artificial milestone percentages would create more precision than the evidence supports.

Several things still point in the same direction. Series B financing has grown sharply. Follow-on rounds are much larger. Industrial humanoid companies are raising more capital without producing more deals. Strategic-backed rounds have moved further up the funding ladder.

Company age gives us an interesting counterpoint. The median funded company is still only two years old. Investors have not simply decided to wait until humanoid startups become old, established businesses.

Recent company announcements help explain what "proof" increasingly looks like. Apptronik has linked its current expansion to Apollo production and deployment. Figure has talked openly about manufacturing, robot fleets, real-world data collection and commercial deployments. X Square's progression through several consecutive rounds has also coincided with increasing backing from large technology groups.

These days, a strong humanoid financing case increasingly involves evidence that the company can move from a working robot toward repeatable production, useful training data and deployment in real environments.

Where is humanoid robotics funding moving right now?

Humanoid robotics money is spreading deeper into the ecosystem, especially toward components, embodied-AI platforms and consumer robots.

Actuation component suppliers stand out. We counted 17 current deals, up from seven, while quantified capital rose from roughly $23 million to $632 million. Their median financing also moved from about $4 million to $28 million.

Humanoid AI platforms expanded more steadily, with deals rising from nine to 12 and capital reaching around $1.09 billion.

Consumer and home robots also became much more visible, moving from three financings to 10.

General-purpose humanoids show a different pattern. Deal count fell from 35 to 29 while their median financing jumped from $14 million to $139 million. Investors are putting far more money behind each selected company.

Industrial labor robots sit somewhere in between. We found eight deals in both periods, yet capital increased from approximately $118 million to $784 million.

This is starting to look like the financing of a full robotics ecosystem. Investors are backing the robot body, the intelligence layer, the components underneath it and the production-oriented companies trying to put these systems to work.

Category	Deals now vs before	Capital now vs before	Median now vs before	What changed
All humanoid robotics	77 vs 63	$6.48B vs $2.56B	$32.3M vs $14M	More companies and bigger rounds
General-purpose humanoids	29 vs 35	$3.55B vs $2.00B	$139M vs $14M	Fewer deals, much larger checks
Actuation component suppliers	17 vs 7	$632M vs $23M	$28M vs $4.15M	Strong growth across the board
Humanoid AI platforms	12 vs 9	$1.09B vs $355M	$39.8M vs $28.2M	More deals and more capital
Industrial labor robots	8 vs 8	$784M vs $118M	$31.4M vs $15.6M	Same breadth, much deeper funding
Consumer home robots	10 vs 3	$416M vs $59M	$29M vs $15.1M	Clear increase in investor attention
Logistics work robots	1 vs 1	$6.5M vs $10M	$6.5M vs $10M	Still too small to read much into

Is China carrying the humanoid robotics funding boom?

China is responsible for most of the current humanoid robotics funding surge in dollars, while its dominance in deal count was already well established.

Chinese financings increased from 51 to 65. Quantified capital made a much bigger move, from roughly $1.05 billion to $5.48 billion, and the median Chinese round rose from $14 million to $29.6 million.

China now represents about 85% of quantified capital in our market.

The latest policy direction lines up closely with that funding pattern. China's Ministry of Industry and Information Technology and the state-assets regulator launched a 2026 real-world training program for humanoid robots and embodied AI. The program covers industrial, service and specialist environments, calls for more than 100 high-value application scenarios and aims to create capacity for deployments at the 10,000-unit level.

China is also building a lifecycle-management framework covering robot production, market entry, operation, maintenance and retirement. That is the kind of infrastructure a market starts needing when it expects more robots to leave laboratories and enter ordinary operating environments.

North America looks much smaller if we compare capital shares, but the previous period was distorted upward by Figure's huge financing and Apptronik's initial Series A. Deal count there actually moved from six to seven. The bigger geographic story is the huge increase in capital per Chinese financing.

Are strategic investors becoming more important in humanoid robotics?

Strategic investors are becoming more important to large humanoid robotics rounds, even though they are not appearing in a greater percentage of deals.

We identified strategic participation in 34 current financings and 33 previously. With the overall market growing, the participation rate fell from 52.4% to 44.2%.

The typical strategic-backed round tells a completely different story. Its median size went from $28 million to $139 million.

Those investors are also showing up later in the funding journey. Strategic-backed Seed deals fell from 10 to five and Series A deals from 13 to eight, while Series B increased from one to seven.

X Square is a useful example. The company says it has received lead-round backing at different stages from Meituan, Alibaba, ByteDance and Xiaomi, alongside financial investors such as HongShan and IDG.

SAIC shows how the industrial version works. The automaker says it has committed more than RMB800 million across humanoid robots and core components, including robot bodies, tactile sensing and roller-screw technology. It is also putting robots from companies it backed onto its own production lines.

Corporate money is increasingly tied to manufacturing capabilities, distribution, technology or an actual place to deploy the robots.

Are more investors entering humanoid robotics now?

Yes. The visible humanoid robotics investor pool has expanded quite a bit.

We identified 109 unique disclosed lead and strategic investor names in the latest period, up from 87. Disclosed lead investors alone increased from 54 to 74.

That is a faster increase than deal count.

Some names keep reappearing. Xiaomi Strategic Investment shows up five times in our current data, while Huakong Fund and Matrix Partners China each appear three times. SAIC Financial Holdings, Baidu and HongShan each appear twice.

Those counts should not be treated as a league table because many rounds do not disclose complete syndicates. They are still useful for seeing how the funding base is changing.

As of now, the market appears to have more investors willing to lead or participate rather than a smaller circle financing all of the growth.

Are humanoid robotics investors becoming more selective?

Yes, especially when deciding which humanoid robotics companies deserve the really large checks.

The number of funded companies is rising, so selectivity is not showing up as a general shutdown of funding access.

The separation happens after that first financing.

Typical entry-round size has barely moved, while later rounds have grown dramatically. General-purpose humanoid companies provide the clearest example: fewer transactions are happening in that category, yet selected companies are raising many times what their peers raised a year earlier.

The stage mix points the same way. A much larger Series B layer has appeared, and corporate investors are increasingly present in those larger rounds.

We therefore see a market with a relatively open front door and a much steeper funding ladder once companies start trying to scale.

Are humanoid robotics companies finally raising money to scale?

Yes. More of the capital in humanoid robotics today is tied to production, deployment, training infrastructure and real-world operation.

We cannot turn use of funds into a clean percentage because those details are not disclosed consistently enough across every financing. The company-level examples are still quite revealing.

Apptronik said its $520 million Series A-X would help scale Apollo production and deployment. The company has also built a network of Robot Park facilities where Apollo robots collect real-world training data across tasks and customer environments.

Figure's large financing similarly covered manufacturing, deployments, GPU infrastructure and data collection. The company has been explicit about the amount of infrastructure needed to train general-purpose physical AI at scale.

China's 2026 deployment program pushes in the same direction, with real-world validation, routine deployment, high-quality robot data and component improvement all built into the policy.

As we saw previously, the funding pattern fits these operating needs: bigger follow-ons, more later-stage rounds and much heavier investment in component suppliers.

The industry is now spending serious money on what happens after a prototype works.

Is humanoid robotics funding getting more concentrated?

Humanoid robotics funding is becoming less concentrated around individual companies while large rounds account for a bigger share of the overall market.

The largest deal represented 39% of quantified funding in the earlier period. That figure is now 8%.

Top-five concentration fell from 67.4% to 29.8%, while the top 10 dropped from 79.3% to 47.1%. A single company therefore has far less power to distort the headline market number.

At the same time, big rounds have multiplied. We counted 29 financings above $50 million versus nine previously, and 25 strictly above $100 million versus four.

Those $100 million-plus rounds now generate more than four-fifths of quantified funding.

The current market is spread across more major winners, with many of them raising at a scale that would have been unusual one year earlier.

Concentration measure	Latest 12M	Previous 12M
Largest deal / capital	8.0%	39.0%
Top 3 / capital	20.6%	58.6%
Top 5 / capital	29.8%	67.4%
Top 10 / capital	47.1%	79.3%
Rounds above $50M	29	9
Rounds strictly above $100M	25	4
Capital from >$50M rounds	86.6%	77.7%
Capital from >$100M rounds	81.7%	64.1%

What really changed in humanoid robotics funding over the last 12 months?

The biggest change is that humanoid robotics now has a much stronger scaling layer. A year ago, early-stage rounds dominated the flow of deals. Today, larger follow-ons and Series B financings are a normal part of the market.

Funding breadth improved at the same time. More companies received capital, new entrants did not disappear, and the disclosed investor base expanded. That makes the current acceleration much harder to dismiss as money simply circulating among the same few businesses.

The next major shift is where the money is going. General-purpose humanoid companies are receiving much bigger checks, while component suppliers, embodied-AI platforms and consumer robots are all attracting more attention. The supply chain around the robots is becoming investable in its own right.

China has become even more important financially. Its share of deal activity was already enormous, but the typical Chinese financing is now much larger. Recent policy also shows a clear push toward real-world deployment, standardization and industrial use.

Investors seem more willing to fund new entrants while reserving the biggest amounts for companies that can show a credible route into production, training and deployment. That creates a wider market at the bottom and a much more aggressive funding ladder at the top.

The most misleading way to describe the last 12 months would be to stop at the 153% increase in total capital. The more useful story is that humanoid robotics has developed a deeper funding market around companies trying to manufacture, train and deploy robots at scale.